[DNA microarrays in the clinic?].
Jordan
Bertrand
B
Marseille-Nice Génopole, case 901, Parc Scientifique de Luminy, 13288 Marseille Cedex 9, France. brjordan@club-internet.fr
D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics; D001711:Biotransformation / Q000235:genetics; D001943:Breast Neoplasms / Q000235:genetics / Q000517:prevention & control; D003550:Cystic Fibrosis / Q000175:diagnosis / Q000235:genetics / Q000517:prevention & control; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics; D065731:Cytochrome P-450 CYP2C19; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics; D005260:Female; D005544:Forecasting; D020869:Gene Expression Profiling; D006580:Genetic Carrier Screening; D030342:Genetic Diseases, Inborn / Q000175:diagnosis* / Q000235:genetics / Q000517:prevention & control; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing / Q000379:methods / Q000706:statistics & numerical data; D014644:Genetic Variation; D006801:Humans; D008297:Male; D006899:Mixed Function Oxygenases / Q000235:genetics; D009386:Neoplastic Syndromes, Hereditary / Q000175:diagnosis / Q000235:genetics / Q000517:prevention & control; D009693:Nucleic Acid Hybridization; D020411:Oligonucleotide Array Sequence Analysis; D011237:Predictive Value of Tests; D011364:Professional Practice; D015203:Reproducibility of Results
C505032:CFTR protein, human; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D006899:Mixed Function Oxygenases; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D019389:Cytochrome P-450 CYP2D6